Chinese team aims to put ‘smart’ diabetes probiotic on US shelves within 2 years

A "smart" probiotic engineered by Chinese researchers could revolutionize diabetes care, potentially making management as simple as consuming yogurt or a capsule. This innovative bacterium is designed to detect elevated blood sugar levels and automatically release a hormone that lowers glucose.

In recent animal trials, the probiotic demonstrated performance on par with Ozempic, a widely used drug for diabetes and weight management. The study detailing these findings was published in the journal Nature last week. The research team at East China Normal University in Shanghai has already secured patents for their invention and is now focusing on scaling up production to meet the stringent pharmaceutical standards required for the U.S. and European markets.

Lead scientist Ye Haifeng expressed optimism in an interview with China Science Daily, stating, "If all goes well, the probiotic is expected to be available in the United States in the form of a health supplement in about two years." This development offers a promising new avenue for managing diabetes, a chronic metabolic disease affecting over 530 million adults globally, with projections indicating a rise to over 850 million by 2050.

“

If all goes well, the probiotic is expected to be available in the United States in the form of a health supplement in about two years.